Vimarsana
Biggest News Aggregation in the World

Offit Rotateq News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Offit Rotateq. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Offit Rotateq Today - Breaking & Trending Today

The Offit Index: Tracking a Patent Owner's Ongoing Financial Interest in One Vaccine's Sales - Vimarsana News

The Offit Index: Tracking a Patent Owner's Ongoing Financial Interest in One Vaccine's Sales

Published: January 16, 2023

ME's Note: We ran this post ten days ago. Seemed valuable to share it again. By Mark Blaxill Vaccine developer Paul Offit has just published a new book, Deadly Choices, in which he turns up the volume and the rhetoric...

Source: ageofautism.com
Related Topics:
United StatesCleveland JacobsDan OlmstedBarbara Loe FisherMerck RotateqJenny MccarthyPaul OffitOffit RotateqGlaxosmithkline RotarixMerck CoMassachusetts Department Of Public HealthWistar InstituteMassachusetts Department Of Public Health EpidemiologistsCutter IncidentFalse ProphetsPaul CapitalOffit IndexVaccine Adverse Event Reporting SystemMassachusetts DepartmentPublic HealthInfect DisDr Paul OffitEadly Choices How The Anti Vaccine Movement Threatens Us AllMark BlaxillAn Oimsted
Counting Offit's Millions: More on How Merck's Rotateq Vaccine Made Paul Offit Wealthy - Vimarsana News

Counting Offit's Millions: More on How Merck's Rotateq Vaccine Made Paul Offit Wealthy

Published: January 16, 2023

By Dan Olmsted and Mark Blaxill Paul Offit, vaccine entrepreneur and public health spokesperson, has earned approximately $10 million in income from Rotateq® royalties through 2009 and stands to earn a total of between $13-35 million over the life of...

Source: ageofautism.com
Related Topics:
United StatesWyeth RotashieldTamy WallaceFred ClarkJake CrosbyRussel KaufmanMerck RotateqWistar RotateqPaul OffitStanley PlotkinOffit RotateqStaci Vernick GoldbergGlaxosmithkline RotarixMerylej MelnicoffGrowth Of The Wistar Institute Licensing IncomeInstitute SheWistar Institute AnnualWistar Institute TechnologyCouncil For GrowthChildren Hospital FoundationMoody Global Credit ResearchRoyalty PharmaPaul Royalty FundPaul Capital The Royalty FundWistar Institute